Market Overview:
The global oral rehydration salts (ORS) market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of diarrhea, especially in infants and children, and rising awareness about the benefits of ORS among consumers. In addition, growing demand for convenient and easy-to-use ORS products is also contributing to the growth of this market. Based on type, the global oral rehydration salts (ORS) market can be segmented into solutions and powders. The solutions segment is expected to account for a larger share than the powders segment in terms of revenue during the forecast period. This can be attributed to their ease of use and high efficacy in treating dehydration caused by diarrhea. Based on application, the global oral rehydration salts (ORS) market can be divided into infants, children, and adults segments. Among these segments,the infants segment is projected to register highest CAGR during 2018–2030 owingto high incidence rateof diarrheain this age group across different regions worldwide .
 Industry Outlook.svg)
Product Definition:
A mixture of salts and sugar which is used to replace fluids and minerals lost through vomiting or diarrhea. ORS is important because it can prevent or treat dehydration, a serious complication of diarrhea.
Solutions:
Solution is a drink mix that contains electrolytes and water. It helps in replacing the fluids lost during diarrhea, vomiting or other stomach illness. The solution can be used with any oral rehydration salts (ORS) preparation such as Dioralyte or Pedialyte.
The global market for oral rehydration solutions was valued at USD 473 million in 2016.
Powders:
Powders and it's usage in Oral Rehydration Salts (ORS) market is a combination of minerals, salts, and sugar that help replace fluids lost due to diarrhea or vomiting. Powdered formulations are usually added to ORS packets along with other liquids to make a complete drink.
The product is available as pre-filled syringes or powders which can be used directly by itself if no water is available.
Application Insights:
Based on the application, the global market has been segmented into infants, children and adults. The infant segment held a major share in 2015 owing to increasing prevalence of dehydration among infants. According to data published by WHO, globally about 1-2% of babies suffer from diarrhea every year. Also, according to estimates published in NCBI (Nationally Consistent Body of Information), about 635-690 million cases of diarrhea occur annually worldwide. Thus due to high incidence rate as well as prevalence rate dehydrated infants are expected to dominate the global oral rehydration salts (ORS) market throughout forecast period.
The child segment is expected register remarkable growth over forecast period owing mainlyto rising numberof children suffering from malnutrition across the globe especially in South East Asia.
Regional Analysis:
Europe dominated the global oral rehydration salts market in 2017 owing to high prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and obesity. According to WHO data in 2016; every year around 4 million people die due to kidney-related problems in Europe. Moreover, increasing geriatric population prone to various health issues is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing rising healthcare expenditure and improving infrastructure for conducting clinical trials. In addition, increasing awareness regarding chronic diseases among adults will propel demand for ORS products over the next eight years.
Growth Factors:
- Increasing awareness about the benefits of ORS among consumers: There is a growing awareness among consumers about the benefits of ORS, which is helping to drive demand for the product.
- Rising incidence of diarrhea and other gastrointestinal disorders: The incidence of diarrhea and other gastrointestinal disorders is on the rise, which is leading to an increase in demand for ORS products.
- Growing popularity of packaged food products: The popularity of packaged food products is rising, as they are considered to be more convenient and healthy than traditional foods. This is benefiting the ORS market as well, as more people are opting for these products over others.
- Rapid urbanization and changing lifestyles: Rapid urbanization and changing lifestyles are leading to an increase in cases of dehydration due to inadequate water intake and increased physical activity levels respectively. This is fueling demand for ORS products worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Rehydration Salts (ORS) Market Research Report
By Type
Solutions, Powders
By Application
Infants, Children, Adults
By Companies
Abbott, Sanofi, Jianas Brothers, Trifecta Pharmaceuticals, Otsuka Pharmaceutical, Watson Pharma, FDC Limited, Multichem NZ Ltd, Shanghai Trifecta Pharma, Tianjin Teda Steyuan Pharm, ZouPing YiKang Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Oral Rehydration Salts (ORS) Market Report Segments:
The global Oral Rehydration Salts (ORS) market is segmented on the basis of:
Types
Solutions, Powders
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infants, Children, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Sanofi
- Jianas Brothers
- Trifecta Pharmaceuticals
- Otsuka Pharmaceutical
- Watson Pharma
- FDC Limited
- Multichem NZ Ltd
- Shanghai Trifecta Pharma
- Tianjin Teda Steyuan Pharm
- ZouPing YiKang Group
 Market Overview.svg)
Highlights of The Oral Rehydration Salts (ORS) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solutions
- Powders
- By Application:
- Infants
- Children
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Rehydration Salts (ORS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
ORS are a type of salt that is used to treat dehydration. ORS can be found in many stores and pharmacies. They are usually in the form of tablets or capsules and should be taken with water.
Some of the major players in the oral rehydration salts (ors) market are Abbott, Sanofi, Jianas Brothers, Trifecta Pharmaceuticals, Otsuka Pharmaceutical, Watson Pharma, FDC Limited, Multichem NZ Ltd, Shanghai Trifecta Pharma, Tianjin Teda Steyuan Pharm, ZouPing YiKang Group.
The oral rehydration salts (ors) market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oral Rehydration Salts (ORS) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oral Rehydration Salts (ORS) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oral Rehydration Salts (ORS) Market - Supply Chain
4.5. Global Oral Rehydration Salts (ORS) Market Forecast
4.5.1. Oral Rehydration Salts (ORS) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oral Rehydration Salts (ORS) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oral Rehydration Salts (ORS) Market Absolute $ Opportunity
5. Global Oral Rehydration Salts (ORS) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Type
5.3.1. Solutions
5.3.2. Powders
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oral Rehydration Salts (ORS) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Application
6.3.1. Infants
6.3.2. Children
6.3.3. Adults
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oral Rehydration Salts (ORS) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oral Rehydration Salts (ORS) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oral Rehydration Salts (ORS) Demand Share Forecast, 2019-2026
9. North America Oral Rehydration Salts (ORS) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Application
9.4.1. Infants
9.4.2. Children
9.4.3. Adults
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Type
9.7.1. Solutions
9.7.2. Powders
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oral Rehydration Salts (ORS) Demand Share Forecast, 2019-2026
10. Latin America Oral Rehydration Salts (ORS) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Application
10.4.1. Infants
10.4.2. Children
10.4.3. Adults
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Type
10.7.1. Solutions
10.7.2. Powders
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oral Rehydration Salts (ORS) Demand Share Forecast, 2019-2026
11. Europe Oral Rehydration Salts (ORS) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Application
11.4.1. Infants
11.4.2. Children
11.4.3. Adults
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Type
11.7.1. Solutions
11.7.2. Powders
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oral Rehydration Salts (ORS) Demand Share, 2019-2026
12. Asia Pacific Oral Rehydration Salts (ORS) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Application
12.4.1. Infants
12.4.2. Children
12.4.3. Adults
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Type
12.7.1. Solutions
12.7.2. Powders
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oral Rehydration Salts (ORS) Demand Share, 2019-2026
13. Middle East & Africa Oral Rehydration Salts (ORS) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Application
13.4.1. Infants
13.4.2. Children
13.4.3. Adults
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oral Rehydration Salts (ORS) Market Size and Volume Forecast by Type
13.7.1. Solutions
13.7.2. Powders
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oral Rehydration Salts (ORS) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oral Rehydration Salts (ORS) Market: Market Share Analysis
14.2. Oral Rehydration Salts (ORS) Distributors and Customers
14.3. Oral Rehydration Salts (ORS) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Jianas Brothers
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Trifecta Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Otsuka Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Watson Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. FDC Limited
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Multichem NZ Ltd
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Shanghai Trifecta Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Tianjin Teda Steyuan Pharm
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. ZouPing YiKang Group
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
